Wearables & Patient-Generated Data: Managing Volume, Variety, and Value

The future of clinical research is being shaped by a single powerful trend: the rise of wearables and patient-generated health data (PGHD). No longer limited to fitness enthusiasts, wearable technologies are now providing clinical-grade data that is transforming how trials are designed, monitored, and evaluated.

From smartwatches to advanced biosensors, the ability to continuously capture patient health data is enabling more patient-centric, decentralized, and efficient trials. But with opportunity comes the challenge of managing the volume, variety, and value of this data.

Real-World Impact on Patients

Wearables have changed the way patients participate in trials:

Reduced site visits: Patients can stay at home while devices collect vital data such as heart rate, blood oxygen levels, or sleep patterns.
Better safety monitoring: Real-time tracking enables faster detection of adverse events, allowing clinicians to intervene earlier.
Higher engagement and retention: Patients who see their own data often feel more connected to the study, leading to improved compliance.

For example, in the Johnson & Johnson Heartline Study, the Apple Watch was used to detect atrial fibrillation in thousands of patients. This large-scale, virtual trial demonstrated both feasibility and the benefit of wearable-driven engagement.

Accelerating the Trial Process

Wearables do not just make trials more patient-friendly—they make them faster and more robust:

Faster recruitment: Remote monitoring allows inclusion of patients from rural or underserved areas.
Richer datasets: Continuous data capture provides a more accurate picture of patient health than occasional site visits.
Adaptive designs: Real-time insights allow sponsors to adjust protocols or dosing strategies mid-trial.

For example, Pfizer leveraged Fitbit devices in neurological studies to monitor sleep and activity. This provided researchers with valuable, real-world insights that were not possible through traditional clinic visits alone.

Tools and Platforms Driving Adoption

Several leading companies are already embedding wearable data into their clinical data management workflows:

Medidata Sensor Cloud: Offers a unified platform to ingest, normalize, and analyze data from multiple wearable devices.
Veeva Vault CDMS: Provides cloud-native integration capabilities for external data streams, including wearable outputs.
Clario: Specializes in clinical-grade sensor solutions widely used in respiratory and cardiovascular trials.
Labcorp’s Covance: Supports decentralized trial models with wearable device integration for continuous remote monitoring.

These platforms are bridging the gap between consumer devices and regulatory-grade clinical datasets.

The Integration Challenge

Bringing wearable data into trial systems is complex. Challenges include:

Volume of Data: Continuous monitoring can generate gigabytes of raw data per patient.
- Solution: Cloud-native CDMS platforms that can scale elastically to store and process high-volume datasets.
Data Variety and Quality: Devices differ in format and accuracy, and patient misuse can create inconsistencies.
- Solution: Use AI-driven data cleaning and industry standards like CDISC ODM to normalize and validate inputs.
Interoperability Issues: Proprietary device formats make it hard to unify data streams.
- Solution: Adoption of standards such as HL7 FHIR to enable seamless interoperability.
Privacy and Compliance: Sensitive health data raises concerns under HIPAA, GDPR, and the European Health Data Space (EHDS).
- Solution: Strong encryption, audit trails, and patient consent frameworks built into CDMS platforms.

The Road Ahead

Wearables and patient-generated health data are no longer experimental—they are becoming a core component of modern clinical research. They benefit patients by reducing burdens, improve trial timelines through richer real-world evidence, and empower sponsors with actionable insights.

As cloud-native platforms, interoperability standards, and AI-based validation mature, the industry will be able to overcome today’s challenges and unlock the full potential of wearables in clinical trials.

The message is clear: wearable data is not just adding numbers to databases—it is adding real value to both patients and science.